(Q32060460)

6 July 2017

1 reference

title

Pharmacology of itraconazole (English)

1 reference

6 July 2017

1 reference

ChEBI release 2020-05-28

1 reference

De Beule K

1

1 reference

6 July 2017

Van Gestel J

series ordinal

2

1 reference

6 July 2017

publication date

1 January 2001

1 reference

6 July 2017

1 reference

6 July 2017

volume

61 Suppl 1

1 reference

6 July 2017

page(s)

27-37

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200161001-00003

6 July 2017

exact match

0 references

cites work

Pharmacokinetics of itraconazole following oral administration to normal volunteers

1 reference

12 December 2020

Itraconazole in cyclodextrin solution

1 reference

12 December 2020

Molecular mechanisms of drug resistance in fungi

1 reference

12 December 2020

Influence of an acidic beverage (Coca-Cola) on the absorption of itraconazole

1 reference

12 December 2020

The influence of food on the pharmacokinetics of itraconazole in patients with superficial fungal infection

1 reference

12 December 2020

Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses

1 reference

12 December 2020

Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units

1 reference

12 December 2020

Systemic antifungal agents. Drug interactions of clinical significance

1 reference

12 December 2020

In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi

1 reference

12 December 2020

P450 inhibitors of use in medical treatment: focus on mechanisms of action

1 reference

12 December 2020

A Double-Blind, Randomized, Placebo-Controlled Trial of Itraconazole Capsules as Antifungal Prophylaxis for Neutropenic Patients

1 reference

12 December 2020

Fungal colonization and infection in children with acute leukemia and lymphoma during induction therapy.

1 reference

12 December 2020

Itraconazole pharmacokinetics in patients with renal dysfunction

1 reference

12 December 2020

The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects.

1 reference

12 December 2020

Optimisation of itraconazole therapy using target drug concentrations.

1 reference

12 December 2020

Food interaction and steady-state pharmacokinetics of itraconazole oral solution in healthy volunteers.

1 reference

12 December 2020

The clinical pharmacokinetics of itraconazole: an overview

1 reference

12 December 2020

Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of fungal infections

1 reference

12 December 2020

Continuous and intermittent itraconazole dosing schedules for the treatment of onychomycosis: a pharmacokinetic comparison

1 reference

12 December 2020

The pharmacokinetics of oral itraconazole in AIDS patients

1 reference

12 December 2020

Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.

1 reference

12 December 2020

Multiple dose pharmacokinetics of an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukaemia.

1 reference

12 December 2020

Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole

1 reference

12 December 2020

Itraconazole and HIV protease inhibitors: an important interaction

1 reference

12 December 2020

In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.

1 reference

12 December 2020

Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiation

1 reference

12 December 2020

Practice guidelines for the management of patients with sporotrichosis. For the Mycoses Study Group. Infectious Diseases Society of America

1 reference

12 December 2020

Oral and intravenous itraconazole for systemic fungal infections in neutropenic haematological patients: meeting report. London, United Kingdom, 20 June 1998

1 reference

12 December 2020

Effect of cyclodextrin on the pharmacology of antifungal oral azoles

1 reference

12 December 2020

Advances in the treatment of superficial fungal infections: focus on onychomycosis and dry tinea pedis.

1 reference

12 December 2020

Prophylaxis of fungal infections with itraconazole during remission-induction therapy

1 reference

12 December 2020

Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche

1 reference

12 December 2020

Effect of food on the pharmacokinetics of a new hydroxypropyl-beta-cyclodextrin formulation of itraconazole.

1 reference

12 December 2020

Itraconazole pharmacokinetics in the female genital tract: plasma and tissue levels in patients undergoing hysterectomy after a single dose of 200 mg itraconazole.

1 reference

12 December 2020

Mycotic infections in pediatric surgical patients.

1 reference

12 December 2020

Drug interactions with itraconazole, fluconazole, and terbinafine and their management

1 reference

12 December 2020

Short report: the absorption of fluconazole and itraconazole under conditions of low intragastric acidity

1 reference

12 December 2020

Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation

1 reference

12 December 2020

In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole

1 reference

12 December 2020

Itraconazole Compared with Griseofulvin in the Treatment of Tinea corporis/cruris and Tinea pedis/manus: An Interpretation of the Clinical Results of all Completed Double-Blind Studies with Respect to the Pharmacokinetic Profile

1 reference

12 December 2020

Itraconazole for treatment of oral candidosis in pediatric cancer patients

1 reference

12 December 2020

Pharmacokinetics of itraconazole (oral solution) in two groups of human immunodeficiency virus-infected adults with oral candidiasis

1 reference

12 December 2020

Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children.

1 reference

12 December 2020

Safety and pharmacokinetics of fluconazole in children with neoplastic diseases

1 reference

12 December 2020

Effects of itraconazole on cytochrome P-450-dependent sterol 14 alpha-demethylation and reduction of 3-ketosteroids in Cryptococcus neoformans

1 reference

12 December 2020

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

1 reference

12 December 2020

Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients

1 reference

12 December 2020

Itraconazole and terbinafine in perspective: from petri dish to patient

1 reference

12 December 2020

Alterations in gastric acidity in patients infected with human immunodeficiency virus

1 reference

12 December 2020

Pharmacokinetic profile of orally administered itraconazole in human skin

1 reference

12 December 2020

Enhanced bioavailability of itraconazole in hydroxypropyl-beta-cyclodextrin solution versus capsules in healthy volunteers.

1 reference

12 December 2020

A pharmacokinetic study of intravenous itraconazole followed by oral administration of itraconazole capsules in patients with advanced human immunodeficiency virus infection

1 reference

12 December 2020

Itraconazole solution: higher serum drug concentrations and better clinical response rates than the capsule formulation in acquired immunodeficiency syndrome patients with candidosis

1 reference

12 December 2020

Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506)

1 reference

12 December 2020

Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplant recipients

1 reference

12 December 2020

Itraconazole penetrates the nail via the nail matrix and the nail bed--an investigation in onychomycosis

1 reference

12 December 2020

Effect of a cola beverage on the bioavailability of itraconazole in the presence of H2 blockers

1 reference

12 December 2020

10.2165/00003495-200161001-00003

Identifiers

DOI

0 references

Dimensions Publication ID

1018579186

0 references

1 reference